Multimorbidity Patterns among People with Type 2 Diabetes Mellitus: Findings from Lima, Peru
Abstract
:1. Introduction
2. Methods
2.1. Data Sources
2.2. Definition of Variables
2.3. Statistical Analysis
2.4. Ethics
3. Results
3.1. Characteristics of the Study Population
3.2. Multiple Chronic Conditions
3.3. Cluster Analysis
4. Discussion
4.1. Main Findings
4.2. Comparison with Previous Studies
4.3. Relevance for Public Health
4.4. Strengths and Limitations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 2016, 387, 1513–1530. [Google Scholar] [CrossRef] [Green Version]
- International Diabetes Federation. IDF Diabetes Atlas, 10th ed.; IDF: Brussels, Belgium, 2021. [Google Scholar]
- Bernabe-Ortiz, A.; Smeeth, L.; Gilman, R.H.; Sanchez-Abanto, J.R.; Checkley, W.; Miranda, J.J.; Study Group, C.C. Development and Validation of a Simple Risk Score for Undiagnosed Type 2 Diabetes in a Resource-Constrained Setting. J. Diabetes Res. 2016, 2016, 8790235. [Google Scholar] [CrossRef] [PubMed]
- Carrillo-Larco, R.M.; Bernabé-Ortiz, A. Type 2 diabetes mellitus in peru: A systematic review of prevalence and incidence in the general population. Rev. Peru. Med. Exp. Salud Publica 2019, 36, 26–36. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Seclen, S.N.; Rosas, M.E.; Arias, A.J.; Huayta, E.; Medina, C.A. Prevalence of diabetes and impaired fasting glucose in Peru: Report from PERUDIAB, a national urban population-based longitudinal study. BMJ Open Diabetes Res. Care 2015, 3, e000110. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bernabé-Ortiz, A.; Carrillo-Larco, R.M.; Gilman, R.H.; Checkley, W.; Smeeth, L.; Miranda, J.J. Contribution of modifiable risk factors for hypertension and type-2 diabetes in Peruvian resource-limited settings. J. Epidemiol. Community Health 2016, 70, 49–55. [Google Scholar] [CrossRef] [PubMed]
- Cicek, M.; Buckley, J.; Pearson-Stuttard, J.; Gregg, E.W. Characterizing Multimorbidity from Type 2 Diabetes: Insights from Clustering Approaches. Endocrinol. Metab. Clin. N. Am. 2021, 50, 531–558. [Google Scholar] [CrossRef]
- Hanlon, P.; Jani, B.D.; Butterly, E.; Nicholl, B.; Lewsey, J.; McAllister, D.A.; Mair, F.S. An analysis of frailty and multimorbidity in 20,566 UK Biobank participants with type 2 diabetes. Commun. Med. 2021, 1, 28. [Google Scholar] [CrossRef] [PubMed]
- Alonso-Morán, E.; Orueta, J.F.; Esteban, J.I.; Axpe, J.M.; González, M.L.; Polanco, N.T.; Loiola, P.E.; Gaztambide, S.; Nuño-Solinís, R. Multimorbidity in people with type 2 diabetes in the Basque Country (Spain): Prevalence, comorbidity clusters and comparison with other chronic patients. Eur. J. Intern. Med. 2015, 26, 197–202. [Google Scholar] [CrossRef]
- Espeland, M.A.; Justice, J.N.; Bahnson, J.; Evans, J.K.; Munshi, M.; Hayden, K.M.; Simpson, F.R.; Johnson, K.C.; Johnston, C.; Kritchevsky, S.R. Eight Year Changes in Multimorbidity and Frailty in Adults with Type 2 Diabetes Mellitus: Associations with Cognitive and Physical Function and Mortality. J. Gerontology. Ser. A 2021, glab342. [Google Scholar] [CrossRef]
- Soji, D.J.; Lordson, J.; Mini, G.K. Multimorbidity patterns among rural adults with Type-2 diabetes mellitus: A cross-sectional study in Kerala, India. WHO South-East Asia J. Public Health 2021, 10, 32–36. [Google Scholar] [CrossRef]
- Abner, S.; Gillies, C.L.; Shabnam, S.; Zaccardi, F.; Seidu, S.; Davies, M.J.; Adeyemi, T.; Khunti, K.; Webb, D.R. Consultation rates in people with type 2 diabetes with and without vascular complications: A retrospective analysis of 141,328 adults in England. Cardiovasc. Diabetol. 2022, 21, 8. [Google Scholar] [CrossRef] [PubMed]
- Sancho-Mestre, C.; Vivas-Consuelo, D.; Alvis-Estrada, L.; Romero, M.; Usó-Talamantes, R.; Caballer-Tarazona, V. Pharmaceutical cost and multimorbidity with type 2 diabetes mellitus using electronic health record data. BMC Health Serv. Res. 2016, 16, 394. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ismail, S.; Stanley, A.; Jeemon, P. Prevalence of multimorbidity and associated treatment burden in primary care settings in Kerala: A cross-sectional study in Malappuram District, Kerala, India. Wellcome Open Res. 2022, 7, 67. [Google Scholar] [CrossRef] [PubMed]
- Nowakowska, M.; Zghebi, S.S.; Ashcroft, D.M.; Buchan, I.; Chew-Graham, C.; Holt, T.; Mallen, C.; Van Marwijk, H.; Peek, N.; Perera-Salazar, R.; et al. The comorbidity burden of type 2 diabetes mellitus: Patterns, clusters and predictions from a large English primary care cohort. BMC Med. 2019, 17, 145. [Google Scholar] [CrossRef] [PubMed]
- The Academy of Medical Sciences. Multimorbidity: A Priority for Global Health Research; The Academy of Medical Sciences: London, UK, 2018. [Google Scholar]
- Hospital de Emergencias Villa El Salvador. Hospital de Emergencias Villa El Salvador: Nuestro Hospital, Lima, Peru. 2021. Available online: https://heves.gob.pe/nuestro-hospital/ (accessed on 8 June 2022).
- World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines; WHO: Geneva, Switzerland, 1992. [Google Scholar]
- Makles, A. Stata tip 110: How to get the optimal k-means cluster solution. Stata J. 2012, 12, 347–351. [Google Scholar] [CrossRef] [Green Version]
- Gower, J.C. A general coefficient of similarity and some of its properties. Biometrics 1971, 27, 857–871. [Google Scholar] [CrossRef]
- Calinski, T.; Harabasz, J. A dendrite method for cluster analysis. Commun. Stat. Theory Methods 1974, 3, 1–27. [Google Scholar] [CrossRef]
- Sarría-Santamera, A.; Orazumbekova, B.; Maulenkul, T.; Gaipov, A.; Atageldiyeva, K. The Identification of Diabetes Mellitus Subtypes Applying Cluster Analysis Techniques: A Systematic Review. Int. J. Environ. Res. Public Health 2020, 17, 9523. [Google Scholar] [CrossRef] [PubMed]
- Pouplier, S.; Olsen, M.; Willadsen, T.G.; Sandholdt, H.; Siersma, V.; Andersen, C.L.; Olivarius, N.F. The development of multimorbidity during 16 years after diagnosis of type 2 diabetes. J. Comorbidity 2018, 8, 2235042X18801658. [Google Scholar] [CrossRef]
- Teljeur, C.; Smith, S.M.; Paul, G.; Kelly, A.; O'Dowd, T. Multimorbidity in a cohort of patients with type 2 diabetes. Eur. J. Gen. Pract. 2013, 19, 17–22. [Google Scholar] [CrossRef]
- Aguado, A.; Moratalla-Navarro, F.; López-Simarro, F.; Moreno, V. MorbiNet: Multimorbidity networks in adult general population. Analysis of type 2 diabetes mellitus comorbidity. Sci. Rep. 2020, 10, 2416. [Google Scholar] [CrossRef] [PubMed]
- Chen, H.; Zhang, Y.; Wu, D.; Gong, C.; Pan, Q.; Dong, X.; Wu, Y.; Zhang, K.; Wang, S.; Lei, J.; et al. Comorbidity in Adult Patients Hospitalized with Type 2 Diabetes in Northeast China: An Analysis of Hospital Discharge Data from 2002 to 2013. BioMed Res. Int. 2016, 2016, 1671965. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gao, F.; Chen, J.; Liu, X.; Wang, X.; Zhao, H.; Han, D.; Jing, X.; Liu, Y.; Cui, Z.; Li, C.; et al. Latent class analysis suggests four classes of persons with type 2 diabetes mellitus based on complications and comorbidities in Tianjin, China: A cross-sectional analysis. Endocr. J. 2017, 64, 1007–1016. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chiang, J.I.; Jani, B.D.; Mair, F.S.; Nicholl, B.I.; Furler, J.; O'Neal, D.; Jenkins, A.; Condron, P.; Manski-Nankervis, J.A. Associations between multimorbidity, all-cause mortality and glycaemia in people with type 2 diabetes: A systematic review. PLoS ONE 2018, 13, e0209585. [Google Scholar] [CrossRef] [PubMed]
- Atun, R.; de Andrade, L.O.; Almeida, G.; Cotlear, D.; Dmytraczenko, T.; Frenz, P.; Garcia, P.; Gómez-Dantés, O.; Knaul, F.M.; Muntaner, C.; et al. Health-system reform and universal health coverage in Latin America. Lancet 2015, 385, 1230–1247. [Google Scholar] [CrossRef]
- Soto, A. Barriers to effective care in the referral hospitals of Peru's Ministry of Health: Serving patients in the 21st century with 20th century resources. Rev. Peru. Med. Exp. Salud Publica 2019, 36, 304–311. [Google Scholar] [CrossRef] [PubMed]
- Ministerio de Salud. Guia de Práctica Clínica para el Diagnóstico, Tratamiento y Control de la Diabetes Mellitus Tipo 2 en el Primer Nivel de Atención; MINSA: Lima, Perú, 2016. [Google Scholar]
- Pesantes, M.A.; Lazo-Porras, M.; Cárdenas, M.K.; Diez-Canseco, F.; Tanaka-Zafra, J.H.; Carrillo-Larco, R.M.; Bernabé-Ortiz, A.; Málaga, G.; Miranda, J.J. Healthcare challenges for people with diabetes during the national state of emergency due to COVID-19 in Lima, Peru: Primary healthcare recommendations. Rev. Peru. Med. Exp. Salud Publica 2020, 37, 541–546. [Google Scholar] [CrossRef]
Overall Sample | By Sex | p-Value | ||
---|---|---|---|---|
Females | Males | |||
(n = 9582) | (n = 5896) | (n = 3686) | ||
Age | 0.01 | |||
<40 years | 877 (9.2%) | 551 (9.4%) | 326 (8.8%) | |
40–49 years | 1577 (16.5%) | 940 (15.9%) | 637 (17.3%) | |
50–59 years | 2539 (26.5%) | 1604 (27.2%) | 935 (25.4%) | |
60–69 years | 2608 (27.2%) | 1632 (27.7%) | 976 (26.5%) | |
70+ years | 1981 (20.6%) | 1169 (19.8%) | 812 (22.0%) | |
Morbidity | ||||
Obesity | 2823 (29.5%) | 1979 (33.6%) | 844 (22.9%) | <0.001 |
Hypertension | 1796 (18.7%) | 1117 (19.0%) | 679 (18.4%) | 0.52 |
Dyslipidemia | 1084 (11.3%) | 786 (13.3%) | 298 (8.1%) | <0.001 |
Hypothyroidism | 616 (6.4%) | 547 (9.3%) | 69 (1.9%) | <0.001 |
Arthropathy | 345 (3.6%) | 275 (4.7%) | 70 (1.9%) | <0.001 |
Chronic kidney disease | 191 (2.0%) | 104 (1.8%) | 87 (2.4%) | 0.04 |
Anemia | 172 (1.8%) | 117 (2.0%) | 55 (1.5%) | 0.08 |
Chronic back pain | 160 (1.7%) | 107 (1.8%) | 53 (1.4%) | 0.16 |
Anxiety | 111 (1.2%) | 79 (1.3%) | 32 (0.9%) | 0.04 |
Cerebrovascular disease | 79 (0.8%) | 35 (0.6%) | 44 (1.2%) | 0.002 |
Tuberculosis | 73 (0.8%) | 27 (0.5%) | 46 (1.3%) | <0.001 |
Cancer | 69 (0.7%) | 46 (0.8%) | 23 (0.6%) | 0.38 |
Heart ischemic disease | 60 (0.6%) | 24 (0.4%) | 36 (1.0%) | <0.001 |
Atrial fibrillation | 52 (0.5%) | 25 (0.4%) | 27 (0.7%) | 0.05 |
Heart failure | 49 (0.5%) | 28 (0.5%) | 21 (0.6%) | 0.53 |
Urinary lithiasis | 40 (0.4%) | 28 (0.5%) | 13 (0.3%) | 0.27 |
Depression | 16 (0.2%) | 14 (0.2%) | 2 (0.1%) | 0.03 |
COPD | 9 (0.1%) | 4 (0.1%) | 5 (0.1%) | 0.29 |
Dementia | 4 (<0.1%) | 1 (<0.1%) | 3 (0.1%) | 0.13 |
Clusters | ||||
---|---|---|---|---|
1 | 2 | 3 | 4 | |
(n = 952) | (n = 4637) | (n = 2823) | (n = 1170) | |
Sex | ||||
Women | 694 (72.9%) | 2539 (54.8%) | 1979 (70.1%) | 684 (58.5%) |
Men | 258 (27.1%) | 2098 (45.2%) | 844 (29.9%) | 486 (41.5%) |
Age | ||||
<40 years | 91 (9.6%) | 457 (9.9%) | 315 (11.2%) | 14 (1.2%) |
40–49 years | 156 (16.4%) | 785 (16.9%) | 568 (20.1%) | 68 (5.8%) |
50–59 years | 257 (27.0%) | 1288 (27.8%) | 773 (27.4%) | 221 (18.9%) |
60–69 years | 261 (27.4%) | 1208 (26.1%) | 746 (26.4%) | 393 (33.6%) |
70+ years | 187 (19.6%) | 899 (19.3%) | 421 (14.9%) | 474 (40.5%) |
Morbidities | ||||
Obesity | 0 (0.0%) | 0 (0.0%) | 2823 (100.0%) | 0 (0.0%) |
Hypertension | 0 (0.0%) | 0 (0.0%) | 677 (24.0%) | 1119 (95.6%) |
Dyslipidemia | 477 (50.1%) | 0 (0.0%) | 483 (17.1%) | 124 (10.6%) |
Hypothyroidism | 274 (28.8%) | 0 (0.0%) | 290 (10.3%) | 52 (4.4%) |
Arthropathy | 130 (13.7%) | 0 (0.0%) | 158 (5.6%) | 57 (4.9%) |
Chronic kidney disease | 3 (0.3%) | 0 (0.0%) | 50 (1.8%) | 138 (11.8%) |
Anemia | 88 (9.2%) | 0 (0.0%) | 39 (1.4%) | 45 (3.9%) |
Chronic back pain | 72 (7.6%) | 0 (0.0%) | 62 (2.2%) | 26 (2.2%) |
Anxiety | 61 (6.4%) | 0 (0.0%) | 34 (1.2%) | 16 (1.4%) |
Sum of morbidities | ||||
None | 0 (0.0%) | 4637 (100.0%) | 0 (0.0%) | 0 (0.0%) |
1 | 809 (85.0%) | 0 (0.0%) | 1506 (53.4%) | 830 (70.9%) |
2 | 133 (14.0%) | 0 (0.0%) | 933 (33.1%) | 285 (24.4%) |
3+ | 10 (1.0%) | 0 (0.0%) | 384 (13.6%) | 55 (4.7%) |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Bernabe-Ortiz, A.; Borjas-Cavero, D.B.; Páucar-Alfaro, J.D.; Carrillo-Larco, R.M. Multimorbidity Patterns among People with Type 2 Diabetes Mellitus: Findings from Lima, Peru. Int. J. Environ. Res. Public Health 2022, 19, 9333. https://doi.org/10.3390/ijerph19159333
Bernabe-Ortiz A, Borjas-Cavero DB, Páucar-Alfaro JD, Carrillo-Larco RM. Multimorbidity Patterns among People with Type 2 Diabetes Mellitus: Findings from Lima, Peru. International Journal of Environmental Research and Public Health. 2022; 19(15):9333. https://doi.org/10.3390/ijerph19159333
Chicago/Turabian StyleBernabe-Ortiz, Antonio, Diego B. Borjas-Cavero, Jimmy D. Páucar-Alfaro, and Rodrigo M. Carrillo-Larco. 2022. "Multimorbidity Patterns among People with Type 2 Diabetes Mellitus: Findings from Lima, Peru" International Journal of Environmental Research and Public Health 19, no. 15: 9333. https://doi.org/10.3390/ijerph19159333